Istvan Ember
Overview
Explore the profile of Istvan Ember including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
71
Citations
415
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Varga C, Ember I, Muranyi E, Kiss I
J Public Health Res
. 2014 Aug;
1(1):45-50.
PMID: 25170445
Hungary, in the centre of Carpathian basin grapples with numerous challenges in order to improve catastrophic indices of environmental conditions of the country, as well as the state of health...
2.
Tibold A, Juhasz K, Gombos K, Gocze K, Ember I
In Vivo
. 2014 Jan;
28(1):55-60.
PMID: 24425836
Several studies have investigated the ecological and genotoxic effects of the red mud accident in 2010 in Ajka, Hungary, but none was designed to reveal the early biological effects of...
3.
Gurzu S, Ciortea D, Ember I, Jung I
Biomed Res Int
. 2013 Aug;
2013:365192.
PMID: 23956979
The Ena/VASP (enabled/vasodilator stimulated phosphoprotein) family includes the binding actin proteins such as mammalian Ena (Mena), VASP, and Ena-VASP-like. It is known that the perturbation of actin cycle could determine...
4.
Stanitz E, Juhasz K, Toth C, Gombos K, Natali P, Ember I
Anticancer Res
. 2013 Jul;
33(8):3195-200.
PMID: 23898078
Aim: Gastric cancer is among the most common causes of cancer-related death worldwide. Since microRNAs (miRNAs) represent an emerging field of cancer research, there is an increasing interest regarding the...
5.
Arany I, Clark J, Reed D, Szabo I, Ember I, Juncos L
Anticancer Res
. 2013 Jul;
33(8):3119-22.
PMID: 23898068
Background/aim: Taxol and dichloroacetic acid (DCA) are anticancer agents with potential renal toxicity. Previously, we have shown that the Ser36-phosphorylated p66shc adaptor protein mediates renal toxicity of selected anticancer modalities...
6.
Mike N, Papp G, certik M, Czibulya Z, Kunsagi-Mate S, Ember I, et al.
Toxicon
. 2013 Jul;
73:130-43.
PMID: 23896534
This study investigates the non-estrogenic mode of zearalenone (ZEA) toxicity in a novel aspect via accumulation of reactive oxygen species (ROS) and the regulation of the activities of antioxidant enzymes...
7.
Orosz E, Ember I, Gombos K, Toth L, Tarpay A, Pap A, et al.
Pathol Oncol Res
. 2013 Jul;
19(4):619-29.
PMID: 23868031
Early diagnosis of recurrence and metastasis of colorectal cancer following surgery of curative intent is of vital importance in terms of survival and quality of life. The consistent implementation of...
8.
Gocze K, Gombos K, Juhasz K, Kovacs K, Kajtar B, Benczik M, et al.
Anticancer Res
. 2013 Jun;
33(6):2561-7.
PMID: 23749909
Cervical cancer is the second leading cause of death among female patients with cancer in the world. Our aim was to analyze cervical cancer cases, in the Southwestern Transdanubian Region...
9.
Gobel G, Szanyi I, Revesz P, Bauer M, Gerlinger I, Nemeth A, et al.
Cancer Genomics Proteomics
. 2013 Apr;
10(2):81-7.
PMID: 23603344
The class of salivary gland tumours is very heterogenous, both in a histopathological and clinical sense. Since they are uncommon lesions, their clinical management is still problematic. Molecular mechanisms underlying...
10.
Gombos K, Horvath R, Szele E, Juhasz K, Gocze K, Somlai K, et al.
Anticancer Res
. 2013 Apr;
33(4):1511-7.
PMID: 23564792
Background: Oral squamous cell carcinoma (OSCC) development involves complex machinery of genomic and epigenetic regulations including microRNA (miRNA) expression changes. We aimed to analyze the expression patterns of a set...